Exploring Fenofibrate Formulations for the Treatment of Lipid Disorders: Past, Present, and Future
CardioMetabolic Syndrome Journal · 2022 · 2 (2) · 77
DOI: 10.51789/cmsj.2022.2.e13 ↗Kurz gefasst
Fachartikel in der Zeitschrift CardioMetabolic Syndrome Journal, 2022. Verfasst von Thu Nhan Nguyen und 1 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Nguyen, T. N., & Park, J. (2022). Exploring Fenofibrate Formulations for the Treatment of Lipid Disorders: Past, Present, and Future. CardioMetabolic Syndrome Journal, 2(2), 77. https://doi.org/10.51789/cmsj.2022.2.e13
Vancouver
Nguyen TN, Park J. Exploring Fenofibrate Formulations for the Treatment of Lipid Disorders: Past, Present, and Future. CardioMetabolic Syndrome Journal. 2022;2(2):77. doi:10.51789/cmsj.2022.2.e13
BibTeX
@article{Nguyen2022,
author = {Nguyen, Thu Nhan and Park, Jeong-Sook},
title = {Exploring Fenofibrate Formulations for the Treatment of Lipid Disorders: Past, Present, and Future},
journal = {CardioMetabolic Syndrome Journal},
year = {2022},
volume = {2},
number = {2},
pages = {77},
doi = {10.51789/cmsj.2022.2.e13}
}
EUVIMED